| EN | ET | RU
National Node of the BCH
Capacity Building Activities, Projects and Opportunities
Record information and status
Record ID
7065
Status
Published
Date of creation
2004-11-15 15:46 UTC (sarah.lukie@croplife.org)
Date of last update
2010-01-18 14:39 UTC (intern.ross.carroll@cbd.int)
Date of publication
2010-01-18 14:39 UTC (intern.ross.carroll@cbd.int)

This document is also available in the following languages:
General information
Title of the initiative
EN
Capacity-Building Efforts of Individual Biotechnology Companies
Beneficiary country(ies)
  • Chile
  • India
  • Indonesia
  • Kenya
  • Malaysia
  • Mexico
  • Philippines
  • Thailand
  • Viet Nam
  • Global
Type of initiative
Main target group(s) / beneficiaries
  • Target group: Developing countries and countries with economies in transition.
Start Date
2004-01-01
Ending date
2004-12-31
Donor(s) information
Agency(ies) or Organization(s) implementing or sponsoring the initiative (Additional Information)
  • Organization: Global Industry Coalition
  • Type of Organization: Industry
Budget information
EN
Individual companies
International research organizations
Private foundations
Bilateral development cooperation agencies
Availability of funds for participants
Yes
Activity details
Description of the initiative
EN
Many individual companies are undertaking different activities in support of biosafety and research, development, transfer and use of biotechnologies in developing countries and countries with economies in transition.  

An example is the Novartis biosafety programme, which has as its purpose to minimize the potential hazards in the handling of biological materials. The company has worked with research institutions in such countries as Indonesia, Philippines, Thailand and Viet Nam to develop their capacities in biotechnology, including specifically on regulatory aspects of field trials, product development and distribution. It is planning to fund a pilot biosafety programme for a selected country in Africa, to be used as a model for other countries.

An other example is Monsanto, which is working with selected research institutions in developing countries to develop biotechnology research capacity related to specific types of LMO products, with companion capacity-building activities in risk assessment and LMO regulation. This has involved work in Kenya, Mexico, Indonesia, Philippines, Thailand, Malaysia and Viet Nam.
Objective and main expected outcomes or lesson learned
EN
Goals
To support research, development, transfer and use of biotechnologies in developing countries and countries with economies in transition.
To minimize the potential hazards in the hadling of biological materials.
To develop capacity-building activities in risk assessment and LMO regulation.
To develop national capacities in biotechnology, including regulatory aspects of field trials, product development and distribution.

Objectives
To develop awareness and capacities for biosafety in developing countries and countries with economies in transition.
General thematic area(s)
  • Institutional capacity
  • Human resources capacity development and training
  • Information exchange and data management including participation in the Biosafety Clearing-House
Additional Information
Additional Information
EN
Other collaborating organizations
Developing country research institutions, regulatory officials, biotechnology industry
OECD country universities
Agribiotechnologia de Costa Rica
AgrEvo GmbH
ANPROS (Chile)
Asgrow Seed
Cargill
Dupont
ELM/Seminis
Monsanto
Mitsubishi Chemicals
Novartis
Pioneer Hi-Bred International
ProAgro (India)
Schering and Zeneca Plant Sciences
ICI